Current and future developments in travelers' diarrhea therapy (Q36505498)

14 August 2017

1 reference

title

Current and future developments in travelers' diarrhea therapy (English)

1 reference

14 August 2017

0 references

2

Herbert L DuPont

1 reference

14 August 2017

Hoonmo L Koo

1

1 reference

14 August 2017

1 June 2006

1 reference

Expert Review of Anti-infective Therapy

14 August 2017

1 reference

14 August 2017

4

1 reference

14 August 2017

417-427

1 reference

14 August 2017

3

1 reference

Travelers' diarrhea: modern concepts and new developments

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Travelers' diarrhea: antimicrobial therapy and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

21 January 2018

Traveller's diarrhoea

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Epidemiology of diarrhea in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Norwalk virus infection associates with secretor status genotyped from sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Norwalk virus infection and disease is associated with ABO histo-blood group type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Pathogenesis of Escherichia coli diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Clinical features and duration of traveler's diarrhea in relation to its etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Persistent diarrhea in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Bacterial overgrowth syndrome after acute nonspecific diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Persistent diarrhea in the returning traveler: think beyond persistent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Antimicrobial-resistant Campylobacter species--a new threat to travelers to Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

In vitro activities of new fluoroquinolones against Campylobacter jejuni and Campylobacter coli isolates obtained from humans in 1980 to 1982 and 1997 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

In vitro activity and fecal concentration of rifaximin after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Therapy of travelers' diarrhea with rifaximin on various continents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Antidiarrheal agents in the treatment of acute diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Adverse Effect of Lomotil Therapy in Shigellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Racecadotril in the treatment of acute watery diarrhea in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Saccharomyces cerevisiae fungemia: an emerging infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Treatment of traveler's diarrhea with ciprofloxacin and loperamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Looking for evidence that personal hygiene precautions prevent traveler's diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Interventions to prevent and control food-borne diseases associated with a reduction in traveler's diarrhea in tourists to Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.3.417

21 January 2018

Identifiers

DOI

10.1586/14787210.4.3.417

1 reference

14 August 2017

1 reference

PubMed ID

16771619